A Phase I, Single Centre, Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability and Pharmacokinetics of Modified-Release Formulations of AZD1446 in Young and Elderly Healthy Japanese Volunteers After Oral Single and Repeated Doses

Trial Profile

A Phase I, Single Centre, Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability and Pharmacokinetics of Modified-Release Formulations of AZD1446 in Young and Elderly Healthy Japanese Volunteers After Oral Single and Repeated Doses

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Dec 2010

At a glance

  • Drugs AZD 1446 (Primary)
  • Indications Alzheimer's disease; Depressive disorders
  • Focus Adverse reactions
  • Most Recent Events

    • 27 Dec 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 12 Oct 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 17 Sep 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top